Patrick Griffin

Companies are pouring billions into AI, but a new KDAN report reveals why legacy PDFs and unstructured data are keeping ROI out of reach for most enterprises.

Invesque's 10-cent take-private deal reveals how private credit titans are quietly absorbing distressed public real estate amid shifting capital markets.

As unvetted AI agents infiltrate SMBs, ESET’s overhauled PROTECT portfolio bundles native AI governance and a $1M warranty for channel partners.

As default natural gas rates jump nearly 30% for October, Albertans face a collision between global energy markets and the reality of regional utility divides.

A federal court orders Dairy Farmers of America to maintain health coverage for laid-off Teamsters, setting a critical precedent for 2026 supply chains.

As multinational enterprises abandon slow wire transfers, Jeeves secures $110 million to scale its stablecoin-native corporate banking platform globally.

As traditional youth broadcasting collapses and AI algorithms take over, a new report demands a digital bill of rights to save Canada's cultural future.

As Western studios grapple with labor disputes, China’s streaming giant iQIYI is fast-tracking AI-generated films and series to solve its margin squeeze.

As global myopia rates surge, the FDA faces a high-stakes showdown over Sydnexis's SYD-101. The outcome will redefine pediatric eye care and supply chains.

As remote work reshapes coastal economies, a private equity-backed fiber challenger is dismantling legacy telecom monopolies across Cape Cod.

As the era of cheap debt ends, Finnish forestry giant Tornator absorbs a massive interest rate jump, leveraging natural capital to secure €300M in green bonds.

As offshore wind bottlenecks threaten the energy transition, a new purpose-built subsea rock installation vessel promises precision and lower emissions.

By replacing paper trails with verified digital milestones, INBULK aims to secure vital grain flows to Egypt and unlock trapped trade finance liquidity.

As paid search costs soar, a regional law firm pivots to segmented media, deploying twin podcasts to court both anxious consumers and tech-forward peers.

Kedrion Biopharma secures Orphan Drug Designation for QIVIGY in Stiff Person Syndrome, leveraging regulatory incentives to build a commercial moat.

As B2B sales cycles stretch to 272 days, a new agentic AI suite leverages the Model Context Protocol to eliminate hallucinations in revenue attribution.

SK Biopharmaceuticals and 1ST Biotherapeutics forge a $314.8M alliance to advance a novel dual-inhibitor, reshaping the global Parkinson's landscape.

As the private capital exit drought deepens, specialized fund finance is no longer optional. Validus's latest hire highlights a critical market shift.

As AI drives a 45 GW expansion in U.S. data centers, Walbridge’s new operational arm, L5 Mission Critical, bridges the gap between construction and operations.

VPT's new FLX Series consolidates discrete power modules into a prequalified chassis, cutting integration times for next-gen space and defense platforms.